Kyowa Kirin is a specialty pharmaceutical company that focuses on developing innovative new drugs in the areas of oncology, nephrology, and immunology. With its headquarters in Galashiels, Scotland, the company operates across Europe and the United States of America, and is known for its commitment to delivering high-quality healthcare solutions.
Acquired by Tokyo-based Kyowa Hakko Kirin Co. Ltd. in 2011, ProStrakan, now known as Kyowa Kirin, has rebranded to present a consistent image worldwide. As part of this rebranding, the company's various country affiliates have adopted the Kyowa Kirin name into their local company titles, while the business itself remains unchanged.
Generated from the website